HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Terrance P Snutch Selected Research

Calcium Channels (Calcium Channel)

1/2021The T-type calcium channel antagonist, Z944, reduces spinal excitability and pain hypersensitivity.
1/2020Pregabalin as a Pain Therapeutic: Beyond Calcium Channels.
1/2018CaV 3.2 drives sustained burst-firing, which is critical for absence seizure propagation in reticular thalamic neurons.
7/2015CaV3.2 calcium channels control NMDA receptor-mediated transmission: a new mechanism for absence epilepsy.
4/2011A novel slow-inactivation-specific ion channel modulator attenuates neuropathic pain.
11/2010Contributions of T-type calcium channel isoforms to neuronal firing.
3/2010Treatments for neuropathic pain differentially affect delayed matching accuracy by macaques: effects of amitriptyline and gabapentin.
4/2009Role of voltage-gated calcium channels in ascending pain pathways.
3/2009Ca(V)2.1 P/Q-type calcium channel alternative splicing affects the functional impact of familial hemiplegic migraine mutations: implications for calcium channelopathies.
10/2005Targeting chronic and neuropathic pain: the N-type calcium channel comes of age.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Terrance P Snutch Research Topics

Disease

19Absence Epilepsy (Childhood Absence Epilepsy)
06/2022 - 03/2004
13Pain (Aches)
01/2022 - 10/2005
13Seizures (Absence Seizure)
01/2021 - 01/2009
10Epilepsy (Aura)
01/2022 - 01/2002
9Neuralgia (Stump Neuralgia)
01/2022 - 10/2005
4Chronic Pain
01/2018 - 10/2005
3Hyperalgesia
01/2021 - 08/2010
3Nervous System Diseases (Neurological Disorders)
01/2021 - 01/2002
3Hypersensitivity (Allergy)
01/2021 - 07/2011
2Schizophrenia (Dementia Praecox)
11/2018 - 05/2009
2Psychotic Disorders (Schizoaffective Disorder)
11/2018 - 01/2002
2Brain Diseases (Brain Disorder)
01/2018 - 01/2016
2Mental Disorders (Mental Disorder)
01/2018 - 01/2016
2Migraine Disorders (Migraine)
01/2017 - 10/2010
2Migraine with Aura (Familial Hemiplegic Migraine)
01/2017 - 03/2009
2Substance-Related Disorders (Drug Abuse)
12/2016 - 06/2008
2Intractable Pain
08/2010 - 10/2005
2Channelopathies
03/2009 - 09/2003
1Autism Spectrum Disorder
01/2020
1Neurodevelopmental Disorders
11/2019
1Status Epilepticus (Complex Partial Status Epilepticus)
11/2019
1Cognitive Dysfunction
11/2019
1Temporal Lobe Epilepsy
11/2019
1Neurobehavioral Manifestations
11/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2018
1Peripheral Nerve Injuries
01/2018
1Stroke (Strokes)
10/2017
1Opioid-Related Disorders (Opiate Addiction)
12/2016
1Memory Disorders (Memory Loss)
10/2016
1Parkinson Disease (Parkinson's Disease)
09/2015
1Nociceptive Pain
10/2014
1Breast Neoplasms (Breast Cancer)
10/2014
1Sleep Initiation and Maintenance Disorders (Insomnia)
05/2014
1Pathologic Processes
05/2014

Drug/Important Bio-Agent (IBA)

26T-Type Calcium Channels (T-Type Calcium Channel)IBA
01/2021 - 01/2002
12Z944IBA
01/2021 - 02/2012
12Calcium Channels (Calcium Channel)IBA
01/2021 - 02/2004
11CalciumIBA
01/2021 - 09/2003
4Analgesics (Analgesic Drugs)IBA
01/2021 - 11/2009
4Ion Channels (Ion Channel)IBA
01/2018 - 04/2011
4Q-Type Calcium Channels (Q-Type Calcium Channel)IBA
01/2017 - 03/2009
3L-Type Calcium Channels (Dihydropyridine Receptor)IBA
01/2020 - 06/2012
3Pregabalin (Lyrica)FDA Link
01/2020 - 08/2010
3N-Type Calcium Channels (N-Type Calcium Channel)IBA
06/2012 - 10/2005
3ziconotide (Prialt)FDA Link
03/2012 - 10/2005
3Peptides (Polypeptides)IBA
08/2010 - 10/2005
2Cannabinoid Receptors (Cannabinoid Receptor)IBA
06/2022 - 01/2021
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
2CannabinoidsIBA
01/2022 - 01/2021
2EnzymesIBA
01/2022 - 11/2019
2Proteins (Proteins, Gene)FDA Link
01/2022 - 10/2017
2Freund's AdjuvantIBA
01/2021 - 05/2018
2Anticonvulsants (Antiepileptic Drugs)IBA
01/2020 - 01/2017
2Gabapentin (Neurontin)FDA LinkGeneric
01/2020 - 03/2010
2Antipsychotic Agents (Antipsychotics)IBA
11/2018 - 01/2002
2voltage-dependent calcium channel (P-Q type)IBA
01/2017 - 03/2009
2Dopamine (Intropin)FDA LinkGeneric
09/2015 - 05/2009
2Ethosuximide (Zarontin)FDA LinkGeneric
01/2015 - 02/2012
2Protein Isoforms (Isoforms)IBA
09/2011 - 11/2010
1Histones (Histone)IBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2022
1CannabidiolIBA
01/2021
1EndocannabinoidsIBA
01/2021
1gamma-Aminobutyric Acid (GABA)IBA
01/2020
1Insulin (Novolin)FDA Link
01/2020
1Kainic Acid (Kainate)IBA
11/2019
1Levetiracetam (Keppra)FDA LinkGeneric
11/2019
1Oxygen (Dioxygen)IBA
12/2018
13,5-diisopropylsalicylic acid (DIPS)IBA
12/2018
1Biomarkers (Surrogate Marker)IBA
12/2018
1Dizocilpine Maleate (Dizocilpine)IBA
11/2018
1MT2 Melatonin ReceptorIBA
05/2018
1MelatoninIBA
05/2018
1Neurotransmitter Agents (Neurotransmitter)IBA
01/2018
1Lipid NanoparticlesIBA
01/2018
1Oxidoreductases (Dehydrogenase)IBA
10/2017
1Sterol Regulatory Element Binding Protein 1IBA
10/2017
1Caspase 3 (Caspase-3)IBA
10/2017
1SterolsIBA
10/2017
1Glutamic Acid (Glutamate)FDA Link
10/2017
1Glyceraldehyde 3-Phosphate (Glyceraldehyde 3 Phosphate)IBA
10/2017
1Carrier Proteins (Binding Protein)IBA
10/2017
1AMPA Receptors (AMPA Receptor)IBA
10/2017
1CalnexinIBA
01/2017
1Plant ExtractsIBA
12/2016
1N-Methylaspartate (NMDA)IBA
07/2015
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2015
1alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
07/2015
1Carbamazepine (Tegretol)FDA LinkGeneric
01/2015
1Insulin-Like PeptidesIBA
10/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
10/2014
1GTP-Binding Proteins (G-Protein)IBA
10/2014
1epigallocatechin gallate (epigallocatechin-3-gallate)IBA
10/2014
1MibefradilIBA
10/2014
1CatalaseIBA
10/2014

Therapy/Procedure

6Therapeutics
01/2020 - 11/2008
3Ligation
06/2012 - 02/2010
2Oral Administration
12/2016 - 04/2011
1Intraperitoneal Injections
01/2021
1Electrodes (Electrode)
11/2019